The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2751094
WO Application Number:
EP2012067027
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP12756693.3
WO Publication Number:
WO2013030374
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United Kingdom (GB)
Publications:
Dates
Filing date:
31/08/2012
Grant date:
20/06/2018
EP Publication Date:
09/07/2014
WO Publication Date:
07/03/2013
Claims Translations Received Date:
Claims Translation B1 Received Date:
28/08/2018
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/09/2020
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
20/06/2018
EP B1 Publication Date:
20/06/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
30/08/2032
Lapsed By Expiration Date:
Patent Validated Date:
07/09/2018
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
20/06/2018
Name:
Glaxo Group Limited
Address:
980 Great West Road, BRENTFORD, MIDDLESEX TW8 9GS, United Kingdom (GB)
Agent
Name:
ir. H.A. Witmans c.s.
From:
06/09/2018
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
Inventor
Name:
LEE, Mei-yin
Address:
Stevenage
Hertfordshire SG1 2NY, United Kingdom (GB)